Potassium Ion

Potassium Ion

SCHEMBL5847292

O=S(=O)([O-])c1ccc(-c2ccc(-c3ccc(-c4ccc(S(=O)(=O)[O-])cc4)cc3)cc2)cc1.[K+].[K+]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 10/20 0.52
▸ CA2 P00918 10/20 0.52
▸ CA9 Q16790 10/20 0.52
▸ CA1 P00915 7/20 0.44
▸ CA14 Q9ULX7 5/20 0.44
▸ LMNA P02545 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PKM P14618 1/20 0.39
▸ KIF11 P52732 1/20 0.38
▸ TSSK1B Q9BXA7 1/20 0.37
▸ MMP2 P08253 1/20 0.37
▸ MMP7 P09237 1/20 0.37
▸ MMP14 P50281 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL9302660 1.00 CA12 (0.52) CA12CA2CA9CA1CA14
SCHEMBL3171668 0.94 CA12 (0.52) CA12CA2CA9CA1CA14
SCHEMBL5846996 0.94 CA12 (0.52) CA12CA2CA9CA1CA14
Potassium Ion SCHEMBL1538011 0.90 LMNA (0.48) CA12CA2CA9CA1CA14
Potassium Ion SCHEMBL2501557 0.89 CA12 (0.60) CA12CA2CA9CA1CA14
Potassium Ion SCHEMBL29427233 0.85 PTGS2 (0.42) CA12CA2CA9CA1CA14
SCHEMBL8662029 0.84 CA12 (0.60) CA12CA2CA9CA1CA14
SCHEMBL11327611 0.84 CA12 (0.60) CA12CA2CA9CA1CA14
SCHEMBL11746260 0.84 CA12 (0.60) CA12CA2CA9CA1CA14
SCHEMBL19953365 0.83 LMNA (0.55) CA12CA2CA9CA1CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200174008-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION 2020-06-04 — — US disclosed
US-10436790-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2019-10-08 — — US disclosed
US-10416166-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2019-09-17 — — US disclosed
EP-3309549-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS Waters Technologies Corporation (US) 2018-04-18 — — EP disclosed
US-9772333-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATER TECHNOLOGIES CORPORATION (US) 2017-09-26 — — US disclosed
EP-2675524-B1 DEVICE AND METHOD FOR TREATMENT OF CELLS AND CELL TISSUE MERCK PATENT GMBH (DE) 2017-05-10 — — EP disclosed
EP-2990401-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MASS SPECTROMETRY SIGNALS Waters Technologies Corporation (US) 2016-03-02 — — EP disclosed
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2014-11-27 — — US disclosed
US-20140242709-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2014-08-28 — — US disclosed
US-20140179011-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2014-06-26 — — US disclosed
US-7151623-B2 Holographic data-storage medium TESA SCRIBOS GMBH (DE) 2006-12-19 — — US disclosed
US-6667830-B1 Super-resolution microscope system and method for illumination JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 CA12 1360/4885CA2 4542/4885CA9 3505/4885
US-10416166-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, CSGALNACT1 CA12 1226/4885CA2 4302/4885CA9 3476/4885
US-20200174008-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 CA12 1360/4885CA2 4542/4885CA9 3505/4885
US-10436790-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, CSGALNACT1 CA12 911/4885CA2 4544/4885CA9 2912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback